Pancreatic ductal adenocarcinoma: Cellular origin, signaling pathways and stroma contribution

Pancreatology

Volumn 8, Issue 4-5, 2008, Pages 462-469

  Hernández Muñoz, Inmaculada ^a   Skoudy, Anouchka ^a   Real, Francisco X ^b,c   Navarro, Pilar ^a,d  

^a INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c Structural Biology and Biocomputing Programme   (Spain)

^d Barcelona Biomedical Research Park   (Spain)

Author keywords

Pancreatic cancer; Pancreatic plasticity; Signal transduction; Stem cell; Tumor stroma

Indexed keywords

BETA CATENIN; CRE RECOMBINASE; CYCLOPAMINE; ELASTASE; K RAS PROTEIN; MATRILYSIN; SONIC HEDGEHOG PROTEIN; UVOMORULIN; WNT PROTEIN;

ACINAR CELL; ANGIOGENESIS; APOPTOSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PREVENTION; CANCER THERAPY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL RENEWAL; CHRONIC PANCREATITIS; CYTOLOGY; DOWN REGULATION; EMBRYO DEVELOPMENT; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE MUTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; ONTOGENY; ORGANOGENESIS; PANCREAS CANCER; PANCREAS DUCT ADENOCARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STROMA;

EID: 49849101934     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000151537     Document Type: Article

References (70)

1. Garcea G, Neal CP, Pattenden CJ, Steward WP, et al: Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005;41:2213-2236.
2. Singh M, Maitra A: Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology 2007;7:9-19.
3. Real FX: A 'catastrophic hypothesis' for pancreas cancer progression. Gastroenterology 2003;124:1958-1964.
4. Hruban RH, Adsay NV, Albores-Saavedra J, et al: Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001;25:579-586.
5. Andea A, Sarkar F, Adsay VN: Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mod Pathol 2003;16:996-1006.
6. Hruban RH, Wilentz RE, Kern SE: Genetic progression in the pancreatic ducts. Am J Pathol 2000;156:1821-1825.
7. Maitra A, Fukushima N, Takaori K, et al: Precursors to invasive pancreatic cancer. Adv Anat Pathol 2005;12:81-91.
8. Sato N, Rosty C, Jansen M, et al: STK11/ LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 2001;159:2017-2022.
9. Adsay NV, Merati K, Basturk O, et al: Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an 'intestinal' pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848.
10. Brembeck FH, Schreiber FS, Deramaudt TB, et al: The mutant K-ras oncogene causes pancreatic periductal lymphocytic infiltration and gastric mucous neck cell hyperplasia in transgenic mice. Cancer Res 2003;63:2005-2009.
11. Bardeesy N, Depinho RA: Pancreatic cancer biology and genetics. Nat Rev Cancer 2002;2:897-909.
12. Pour PM, Standop J, Batra SK: Are islet cells the gatekeepers of the pancreas? Pancreatology 2002;2:440-448.
13. Strobel O, Dor Y, Stirman A, et al: Beta cell transdifferentiation does not contribute to preneoplastic/metaplastic ductal lesions of the pancreas by genetic lineage tracing in vivo. Proc Natl Acad Sci USA 2007;104:4419-4424.
14. Parsa I, Longnecker DS, Scarpelli DG, et al: Ductal metaplasia of human exocrine pancreas and its association with carcinoma. Cancer Res 1985;45:1285-1290.
15. Wagner M, Greten FR, Weber CK, et al: A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease. Genes Dev 2001;15:286-293.
16. Sandgren EP, Quaife CJ, Paulovich AG, et al: Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc Natl Acad Sci USA 1991;88:93-97.
17. Aguirre AJ, Bardeesy N, Sinha M, et al: Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes Dev 2003;17:3112-3126.
18. Hingorani SR, Petricoin EF, Maitra A, et al: Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003;4:437-450.
19. Hingorani SR, Wang L, Multani AS, et al: Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 2005;7:469-483.
20. Tuveson DA, Zhu L, Gopinathan A, et al: Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Res 2006;66:242-247.
21. Guerra C, Schuhmacher AJ, Cañamero M, et al: Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 2007;11:291-302.
22. Stanger BZ, Stiles B, Lauwers GY, et al: Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 2005;8:185-195.
23. Li C, Heidt DG, Dalerba P, et al: Identification of pancreatic cancer stem cells. Cancer Res 2007;67:1030-1037.
24. Hermann PC, Huber SL, Herrler T, et al: Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007;1:313-323
25. Kim SK, MacDonald RJ: Signaling and transcriptional control of pancreatic organogenesis. Curr Opin Genet Dev 2002;12:540-547.
26. Jensen J: Gene regulatory factors in pancreatic development. Dev Dyn 2004;229:176-200.
27. Murtaugh LC, Stanger BZ, Kwan KM, et al: Notch signaling controls multiple steps of pancreatic differentiation. Proc Natl Acad Sci USA 2003;100:14920-14925.
28. Esni F, Ghosh B, Biankin AV, et al: Notch inhibits PTF1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development 2004;131:4213-4224.
29. Apelqvist A, Li H, Sommer L, Beatus P, et al: Notch signalling controls pancreatic cell differentiation. Nature 1999;400:877-881.
30. Jensen J, Pedersen EE, Galante P, et al: Control of endodermal endocrine development by Hes-1. Nat Genet 2000;24:36-44.
31. Beres TM, Masui T, Swift GH, et al: PTF1 is an organ-specific and Notch-independent basic helix-loop-helix complex containing the mammalian Suppressor of Hairless (RBP-J) or its paralogue, RBP-L. Mol Cell Biol 2006;26:117-130.
32. Ghosh B, Leach SD: Interactions between Hairy/Enhancer of Split-related proteins and the pancreatic transcription factor Ptf1-p48 modulate function of the PTF1 transcriptional complex. Biochem J 2006;393:679-685.
33. Rooman I, De Medts N, Baeyens L, et al: Expression of the Notch signaling pathway and effect on exocrine cell proliferation in adult rat pancreas. Am J Pathol 2006;169:1206-1214.
34. Miyamoto Y, Maitra A, Ghosh B, et al: Notch mediates TGFα-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 2003;3:565-576.
35. Means AL, Meszoely IM, Suzuki K, et al: Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development 2005;132:3767-3776.
36. Sawey ET, Johnson JA, Crawford HC: Matrix metalloproteinase 7 controls pancreatic acinar cell transdifferentiation by activating the Notch signaling pathway. Proc Natl Acad Sci USA 2007;104:19327-19332.
37. van den Brink GR: Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol Rev 2007;87:1343-1375.
38. Apelqvist A, Ahlgren U, Edlund H: Sonic hedgehog directs specialised mesoderm differentiation in the intestine and pancreas. Curr Biol 1997;7:801-804.
39. Hebrok M, Kim SK, St Jacques B, et al: Regulation of pancreas development by hedgehog signaling. Development 2000;127:4905-4913.
40. Kayed H, Kleeff J, Keleg S, et al: Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer. Int J Cancer 2004;110:668-676.
41. Pasca di Magliano M, Sekine S, Ermilov A, et al: Hedgehog/Ras interactions regulate early stages of pancreatic cancer. Genes Dev 2006;20:3161-3173.
42. Thayer SP, di Magliano MP, Heiser PW, et al: Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003;425:851-856.
43. Prasad NB, Biankin AV, Fukushima N, et al: Gene expression profiles in pancreatic intraepithelial neoplasia reflect the effects of Hedgehog signaling on pancreatic ductal epithelial cells. Cancer Res 2005;65:1619-1626.
44. Morton JP, Mongeau ME, Klimstra DS, et al: Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci USA 2007;104:5103-5108.
45. Heiser PW, Lau J, Taketo MM, et al: Stabilization of beta-catenin impacts pancreas growth. Development 2006;133:2023-2032.
46. Murtaugh LC, Law AC, Dor Y, et al: Betacatenin is essential for pancreatic acinar but not islet development. Development 2005;132:4663-4674.
47. Dessimoz J, Bonnard C, Huelsken J, et al: Pancreas-specific deletion of beta-catenin reveals Wnt-dependent and Wnt-independent functions during development. Curr Biol 2005;15:1677-1683.
48. Wells JM, Esni F, Boivin GP, et al: Wnt/beta-catenin signaling is required for development of the exocrine pancreas. BMC Dev Biol 2007;7:4.
49. Papadopoulou S, Edlund H: Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 2005;54:2844-2851.
50. Strom A, Bonal C, Ashery-Padan R, et al: Unique mechanisms of growth regulation and tumor suppression upon Apc inactivation in the pancreas. Development 2007;134:2719-2725.
51. Abraham SC, Klimstra DS, Wilentz RE, et al: Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 2002;160:1361-1369.
52. Abraham SC, Wu TT, Hruban RH, et al: Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002;160:953-962.
53. Tanaka Y, Kato K, Notohara K, et al: Frequent beta-catenin mutation and cytoplasmic/ nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001;61:8401-8404.
54. Pujal J, CapellàG, Real FX: The Wnt pathway is active in a small subset of pancreas cancer cell lines. Biochim Biophys Acta 2005;1762:73-79.
55. Al-Aynati MM, Radulovich N, Riddell RH, et al: Epithelial-cadherin and beta-catenin expression changes in pancreatic intraepithelial neoplasia. Clin Cancer Res 2004;10:1235-1240.
56. Lowy AM, Fenoglio-Preiser C, Kim OJ, et al: Dysregulation of beta-catenin expression correlates with tumor differentiation in pancreatic duct adenocarcinoma. Ann Surg Oncol 2003;10:284-290.
57. Pasca di Magliano M, Biankin AV, Heiser PW, et al: Common activation of canonical Wnt signaling in pancreatic adenocarcinoma. PLoS ONE. 2007;2:e1155.
58. Lowenfels AB, Maisonneuve P, DiMagno EP, et al: Hereditary pancreatitis and the risk of pancreatic cancer. J Natl Cancer Inst 1997;89:442-446.
59. Löhr M, Klöppel G, Maisonneuve P, et al: Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis. Neoplasia 2005;7:17-23.
60. Gukovsky I, Gukovskaya AS, Blinman TA, et al: Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 1998;275:1402-1414.
61. Chu GC, Kimmelman AC, Hezel AF, et al: Stromal biology of pancreatic cancer. J Cell Biochem 2007;101:887-907.
62. Patocs A, Zhang L, Xu Y, et al: Breast-cancer stromal cells with TP53 mutations and nodal metastases. N Engl J Med 2007;357:2543-2551.
63. Bhowmick NA, Chytil A, Plieth D, et al: TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848-851.
64. Bierie B, Moses HL: Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer. Nat Rev Cancer 2006;6:506-520.
65. MassaguéJ, Seoane J, Wotton D: Smad transcription factors. Genes Dev 2005;19:2783-2810.
66. Truty MJ, Urrutia R: Basics of TGF-beta and pancreatic cancer. Pancreatology 2007;7:423-435.
67. Bardeesy N, Cheng KH, Berger JH, et al: Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 2006;20:3130-3146.
68. Ellenrieder V, Hendler SF, Boeck W, et al: Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 2001;61:4222-4228.
69. Nakajima S, Doi R, Toyoda E, et al: N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma. Clin Cancer Res 2004;10:4125-4133.
70. Zeisberg M, Yang C, Martino M, et al: Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 2007;282:23337-23347.